These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

276 related articles for article (PubMed ID: 11895981)

  • 1. Early enhanced Th1 response after Leishmania amazonensis infection of C57BL/6 interleukin-10-deficient mice does not lead to resolution of infection.
    Jones DE; Ackermann MR; Wille U; Hunter CA; Scott P
    Infect Immun; 2002 Apr; 70(4):2151-8. PubMed ID: 11895981
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vaccine-induced protection against Leishmania amazonensis is obtained in the absence of IL-12/23p40.
    Hernández MX; Barçante TA; Vilela L; Tafuri WL; Afonso LC; Vieira LQ
    Immunol Lett; 2006 May; 105(1):38-47. PubMed ID: 16466810
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of interleukin-10 in susceptibility of BALB/c mice to infection with Leishmania mexicana and Leishmania amazonensis.
    Padigel UM; Alexander J; Farrell JP
    J Immunol; 2003 Oct; 171(7):3705-10. PubMed ID: 14500669
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IL-4-independent inhibition of IL-12 responsiveness during Leishmania amazonensis infection.
    Jones DE; Buxbaum LU; Scott P
    J Immunol; 2000 Jul; 165(1):364-72. PubMed ID: 10861073
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disruption of the murine interleukin-4 gene inhibits disease progression during Leishmania mexicana infection but does not increase control of Leishmania donovani infection.
    Satoskar A; Bluethmann H; Alexander J
    Infect Immun; 1995 Dec; 63(12):4894-9. PubMed ID: 7591152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Platelet activating factor receptor-deficient mice present delayed interferon-gamma upregulation and high susceptibility to Leishmania amazonensis infection.
    Santiago HC; Braga Pires MF; Souza DG; Roffê E; Côrtes DF; Tafuri WL; Teixeira MM; Vieira LQ
    Microbes Infect; 2006 Sep; 8(11):2569-77. PubMed ID: 16938478
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Short-term protection conferred by Leishvacin® against experimental Leishmania amazonensis infection in C57BL/6 mice.
    Carneiro MB; de Andrade e Sousa LM; Vaz LG; Dos Santos LM; Vilela L; de Souza CC; Gonçalves R; Tafuri WL; Afonso LC; Côrtes DF; Vieira LQ
    Parasitol Int; 2014 Dec; 63(6):826-34. PubMed ID: 25102355
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nonhealing infection despite Th1 polarization produced by a strain of Leishmania major in C57BL/6 mice.
    Anderson CF; Mendez S; Sacks DL
    J Immunol; 2005 Mar; 174(5):2934-41. PubMed ID: 15728505
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phlebotomus papatasi sand fly salivary gland lysate down-regulates a Th1, but up-regulates a Th2, response in mice infected with Leishmania major.
    Mbow ML; Bleyenberg JA; Hall LR; Titus RG
    J Immunol; 1998 Nov; 161(10):5571-7. PubMed ID: 9820534
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deletion of IL-4Ralpha on CD4 T cells renders BALB/c mice resistant to Leishmania major infection.
    Radwanska M; Cutler AJ; Hoving JC; Magez S; Holscher C; Bohms A; Arendse B; Kirsch R; Hunig T; Alexander J; Kaye P; Brombacher F
    PLoS Pathog; 2007 May; 3(5):e68. PubMed ID: 17500591
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cysteine protease B of Leishmania mexicana inhibits host Th1 responses and protective immunity.
    Buxbaum LU; Denise H; Coombs GH; Alexander J; Mottram JC; Scott P
    J Immunol; 2003 Oct; 171(7):3711-7. PubMed ID: 14500670
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Endogenous interleukin-12 is critical for controlling the late but not the early stage of Leishmania mexicana infection in C57BL/6 mice.
    Aguilar Torrentera F; Laman JD; Van Meurs M; Adorini L; Muraille E; Carlier Y
    Infect Immun; 2002 Sep; 70(9):5075-80. PubMed ID: 12183555
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interferon-gamma is required for the late but not early control of Leishmania amazonensis infection in C57Bl/6 mice.
    Pinheiro RO; Rossi-Bergmann B
    Mem Inst Oswaldo Cruz; 2007 Feb; 102(1):79-82. PubMed ID: 17294004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immune responses associated with susceptibility of C57BL/10 mice to Leishmania amazonensis.
    Afonso LC; Scott P
    Infect Immun; 1993 Jul; 61(7):2952-9. PubMed ID: 8514400
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Protection of C3HeB/FeJ mice against Leishmania amazonensis challenge after previous Leishmania major infection.
    Vanloubbeeck Y; Jones DE
    Am J Trop Med Hyg; 2004 Oct; 71(4):407-11. PubMed ID: 15516635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mice with STAT6-targeted gene disruption develop a Th1 response and control cutaneous leishmaniasis.
    Stamm LM; Räisänen-Sokolowski A; Okano M; Russell ME; David JR; Satoskar AR
    J Immunol; 1998 Dec; 161(11):6180-8. PubMed ID: 9834104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Type I IFNs promote the early IFN-gamma response and the IL-10 response in Leishmania mexicana infection.
    Buxbaum LU
    Parasite Immunol; 2010 Feb; 32(2):153-60. PubMed ID: 20070829
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CD4+ Th1 cells induced by dendritic cell-based immunotherapy in mice chronically infected with Leishmania amazonensis do not promote healing.
    Vanloubbeeck YF; Ramer AE; Jie F; Jones DE
    Infect Immun; 2004 Aug; 72(8):4455-63. PubMed ID: 15271903
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired expression of inflammatory cytokines and chemokines at early stages of infection with Leishmania amazonensis.
    Ji J; Sun J; Soong L
    Infect Immun; 2003 Aug; 71(8):4278-88. PubMed ID: 12874303
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro indomethacin administration upregulates interleukin-12 production and polarizes the immune response towards a Th1 type in susceptible BALB/c mice infected with Leishmania mexicana.
    Pérez-Santos JL; Talamás-Rohana P
    Parasite Immunol; 2001 Nov; 23(11):599-606. PubMed ID: 11703811
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.